RBC Capital maintains Ducommun stock rating with $150 target By Investing.com

RBC Capital reiterated an Outperform rating on Ducommun with a $150 price target, about 6% above the current $140.68 share price. The company kept its 2026 guidance for mid-single-digit to high-single-digit revenue growth, and RBC said the strong start to the year adds confidence, though commercial aerospace still faces de-stocking headwinds and revenue there is expected to be down 5% for the remainder of the year. Recent Q1 2026 results were mixed, with revenue ahead of estimates but earnings below expectations.

Analysis

The market is still treating this as a narrow AI-beta flush, but the more interesting signal is the dispersion underneath it. If policy noise around AI capex is enough to hit semiconductor multiples in one session, the basket is becoming increasingly vulnerable to a narrative unwind, especially for the highest-duration names that have already priced in several years of flawless demand. That argues for continued factor pressure on NVDA relative to the broader market until the next hard data point on hyperscaler spending or export-policy clarity.

DCO is a different setup: the guidance tone suggests an underappreciated quality upgrade in the industrial/defense supply chain, where incremental revenue visibility is becoming more valuable than pure growth. If commercial aerospace de-stocking is still a drag but the company is holding guidance, that implies backlog resilience and operating leverage can show up later than consensus expects, likely over the next 2-3 quarters. The second-order effect is that suppliers with exposure to defense and mission-critical programs should trade better than commercial aero peers as investors re-rate earnings durability.

The contrarian read is that the AI selloff may be overextended if the catalyst is primarily sentiment rather than a change in end-demand. These drawdowns often reverse quickly once the market realizes the implication is timing, not cancellation, of capex. But the burden of proof shifts to management teams: any hint of delayed AI deployments or procurement scrutiny could keep the group under pressure for weeks, not days.

Key Decisions for Investors

• Tactically short NVDA into strength over the next 1-3 weeks via calls or stock against a market hedge; risk/reward favors another 5-10% downside if AI capex narratives stay uncertain, but cover quickly on any hyperscaler commentary.
• Long DCO on a 1-3 month horizon; use pullbacks toward the low-140s to add, with a stop below the recent breakout area. The setup is a steady re-rating toward fair value if guidance credibility holds and aerospace destocking normalizes.
• Pair trade: long DCO / short a commercial-aerospace supplier with more cyclical revenue exposure for a 2-4 quarter horizon. The goal is to isolate backlog quality and defense mix, which should outperform if growth slows but doesn't break.
• Use NVDA downside protection rather than outright liquidation if already long core AI exposure: buy 1-2 month puts financed by covered calls. This preserves upside if the move is just a factor shock, while limiting drawdown if policy headlines continue.
• Watch for a reversal catalyst in NVDA only after the next major hyperscaler capex update; until then, the group remains vulnerable to multiple compression even if fundamentals stay intact.